| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Sulfide | 35 | 2025 | 77 | 13.030 |
Why?
|
| Nitric Oxide | 53 | 2025 | 386 | 11.740 |
Why?
|
| Aspirin | 34 | 2025 | 89 | 9.580 |
Why?
|
| Neoplasms | 28 | 2024 | 1377 | 6.000 |
Why?
|
| Nitrates | 21 | 2025 | 63 | 5.500 |
Why?
|
| Antineoplastic Agents | 24 | 2024 | 1019 | 4.630 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 21 | 2022 | 146 | 4.190 |
Why?
|
| Signal Transduction | 25 | 2024 | 2157 | 3.850 |
Why?
|
| Diabetes Mellitus, Type 2 | 26 | 2025 | 760 | 3.600 |
Why?
|
| Disulfides | 9 | 2020 | 95 | 3.400 |
Why?
|
| Nitric Oxide Donors | 21 | 2025 | 41 | 3.290 |
Why?
|
| Carbon Monoxide | 6 | 2025 | 47 | 2.780 |
Why?
|
| Cell Proliferation | 21 | 2024 | 1455 | 2.600 |
Why?
|
| Nitric Oxide Synthase Type II | 10 | 2025 | 128 | 2.100 |
Why?
|
| NF-kappa B | 11 | 2023 | 358 | 1.890 |
Why?
|
| Animals | 79 | 2025 | 16992 | 1.860 |
Why?
|
| Cyclooxygenase Inhibitors | 6 | 2015 | 28 | 1.700 |
Why?
|
| Humans | 90 | 2025 | 43102 | 1.570 |
Why?
|
| Diabetes Mellitus, Experimental | 12 | 2023 | 131 | 1.570 |
Why?
|
| Parkinson Disease | 2 | 2025 | 210 | 1.560 |
Why?
|
| Colonic Neoplasms | 13 | 2015 | 223 | 1.550 |
Why?
|
| Receptors, Estrogen | 3 | 2024 | 183 | 1.550 |
Why?
|
| Anticholesteremic Agents | 2 | 2023 | 25 | 1.470 |
Why?
|
| Rats, Wistar | 24 | 2025 | 283 | 1.450 |
Why?
|
| beta Catenin | 7 | 2013 | 78 | 1.450 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2024 | 347 | 1.350 |
Why?
|
| Inflammation | 5 | 2025 | 758 | 1.350 |
Why?
|
| Cyclooxygenase 2 | 10 | 2022 | 107 | 1.280 |
Why?
|
| Rats | 35 | 2025 | 3735 | 1.220 |
Why?
|
| Cell Line, Tumor | 19 | 2024 | 2676 | 1.120 |
Why?
|
| Thiones | 3 | 2011 | 5 | 1.090 |
Why?
|
| HT29 Cells | 15 | 2021 | 60 | 1.040 |
Why?
|
| Macrophages | 3 | 2023 | 529 | 1.030 |
Why?
|
| Anticarcinogenic Agents | 5 | 2015 | 77 | 1.030 |
Why?
|
| Apoptosis | 16 | 2024 | 1568 | 1.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 5 | 2022 | 27 | 0.950 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2022 | 968 | 0.950 |
Why?
|
| Obesity | 8 | 2024 | 1151 | 0.940 |
Why?
|
| Eicosanoids | 1 | 2025 | 6 | 0.930 |
Why?
|
| Naproxen | 3 | 2015 | 9 | 0.920 |
Why?
|
| Parkinsonian Disorders | 1 | 2025 | 42 | 0.890 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 1723 | 0.890 |
Why?
|
| Cell Cycle | 12 | 2015 | 346 | 0.880 |
Why?
|
| Cholesterol, LDL | 2 | 2023 | 73 | 0.880 |
Why?
|
| Nerve Degeneration | 1 | 2025 | 111 | 0.870 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 89 | 0.870 |
Why?
|
| Glucose | 3 | 2024 | 244 | 0.870 |
Why?
|
| Growth Inhibitors | 4 | 2011 | 29 | 0.860 |
Why?
|
| Sulindac | 2 | 2015 | 9 | 0.830 |
Why?
|
| Inflammation Mediators | 1 | 2025 | 140 | 0.830 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 5 | 2013 | 41 | 0.810 |
Why?
|
| Carbohydrate Metabolism | 2 | 2020 | 26 | 0.780 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 57 | 0.770 |
Why?
|
| Hypercholesterolemia | 1 | 2023 | 42 | 0.770 |
Why?
|
| Neuroprotective Agents | 2 | 2025 | 269 | 0.770 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2022 | 31 | 0.760 |
Why?
|
| Motor Activity | 1 | 2025 | 437 | 0.750 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2020 | 1124 | 0.740 |
Why?
|
| Mice, Nude | 6 | 2024 | 408 | 0.740 |
Why?
|
| Nanostructures | 1 | 2024 | 161 | 0.740 |
Why?
|
| Prodrugs | 3 | 2012 | 31 | 0.740 |
Why?
|
| Muscular Diseases | 1 | 2022 | 22 | 0.730 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 532 | 0.690 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 99 | 0.680 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2023 | 51 | 0.680 |
Why?
|
| Lipoproteins | 1 | 2021 | 70 | 0.680 |
Why?
|
| Gastric Mucosa | 4 | 2021 | 65 | 0.660 |
Why?
|
| Neoplasms, Experimental | 2 | 2021 | 38 | 0.650 |
Why?
|
| Chemoprevention | 4 | 2015 | 41 | 0.630 |
Why?
|
| Gluconeogenesis | 4 | 2025 | 15 | 0.630 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 74 | 0.610 |
Why?
|
| Cyclooxygenase 1 | 3 | 2015 | 13 | 0.610 |
Why?
|
| Pancreatic Neoplasms | 3 | 2020 | 218 | 0.610 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2025 | 187 | 0.550 |
Why?
|
| Hypertension | 2 | 2022 | 835 | 0.550 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 138 | 0.540 |
Why?
|
| Sulfides | 4 | 2023 | 78 | 0.530 |
Why?
|
| Antioxidants | 3 | 2023 | 443 | 0.530 |
Why?
|
| Azo Compounds | 2 | 2023 | 17 | 0.520 |
Why?
|
| Sodium Nitrite | 3 | 2021 | 5 | 0.520 |
Why?
|
| Transcription Factors | 4 | 2010 | 735 | 0.520 |
Why?
|
| Liver | 5 | 2025 | 511 | 0.510 |
Why?
|
| Mice | 14 | 2024 | 6644 | 0.500 |
Why?
|
| Brain | 1 | 2024 | 1472 | 0.500 |
Why?
|
| Inhibitory Concentration 50 | 5 | 2015 | 99 | 0.480 |
Why?
|
| Dinoprostone | 4 | 2022 | 64 | 0.460 |
Why?
|
| Nitrites | 5 | 2023 | 55 | 0.460 |
Why?
|
| Oxidative Stress | 4 | 2025 | 1003 | 0.450 |
Why?
|
| Male | 27 | 2025 | 23409 | 0.450 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2025 | 75 | 0.440 |
Why?
|
| Nitric Oxide Synthase | 7 | 2025 | 135 | 0.430 |
Why?
|
| Hypoglycemic Agents | 3 | 2025 | 184 | 0.430 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1070 | 0.430 |
Why?
|
| Citrulline | 3 | 2024 | 14 | 0.430 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2011 | 18 | 0.420 |
Why?
|
| Caspase 3 | 4 | 2020 | 227 | 0.410 |
Why?
|
| Structure-Activity Relationship | 7 | 2021 | 506 | 0.410 |
Why?
|
| Glutathione Transferase | 2 | 2011 | 90 | 0.410 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2011 | 10 | 0.410 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2010 | 20 | 0.410 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2013 | 8 | 0.400 |
Why?
|
| Flurbiprofen | 1 | 2013 | 5 | 0.400 |
Why?
|
| Wound Healing | 3 | 2024 | 88 | 0.400 |
Why?
|
| Molecular Structure | 5 | 2015 | 570 | 0.400 |
Why?
|
| Osteoporosis | 2 | 2025 | 45 | 0.400 |
Why?
|
| Morpholines | 1 | 2013 | 72 | 0.390 |
Why?
|
| Diabetes Mellitus | 3 | 2025 | 539 | 0.390 |
Why?
|
| Wnt Proteins | 2 | 2010 | 23 | 0.390 |
Why?
|
| Chimera | 1 | 2012 | 18 | 0.390 |
Why?
|
| Oxidation-Reduction | 3 | 2024 | 457 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 92 | 0.380 |
Why?
|
| Ibuprofen | 2 | 2012 | 34 | 0.380 |
Why?
|
| Exercise | 1 | 2019 | 692 | 0.380 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 1596 | 0.380 |
Why?
|
| Adipose Tissue | 3 | 2024 | 182 | 0.370 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2011 | 5 | 0.370 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2011 | 3 | 0.370 |
Why?
|
| Intracellular Membranes | 2 | 2011 | 36 | 0.360 |
Why?
|
| Cell Communication | 1 | 2013 | 114 | 0.360 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2011 | 52 | 0.350 |
Why?
|
| Hyperalgesia | 3 | 2020 | 24 | 0.350 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 186 | 0.350 |
Why?
|
| Cystathionine gamma-Lyase | 3 | 2020 | 15 | 0.350 |
Why?
|
| Glioblastoma | 2 | 2023 | 74 | 0.340 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 53 | 0.340 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2011 | 92 | 0.340 |
Why?
|
| S-Nitrosothiols | 1 | 2010 | 4 | 0.330 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 9 | 0.330 |
Why?
|
| Hydrazines | 1 | 2010 | 22 | 0.330 |
Why?
|
| Adipose Tissue, Brown | 2 | 2022 | 46 | 0.320 |
Why?
|
| Leukemia, T-Cell | 1 | 2010 | 6 | 0.320 |
Why?
|
| Jurkat Cells | 4 | 2013 | 87 | 0.320 |
Why?
|
| Cystathionine beta-Synthase | 2 | 2020 | 16 | 0.310 |
Why?
|
| Piperazines | 1 | 2010 | 120 | 0.310 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 512 | 0.310 |
Why?
|
| Cytoskeletal Proteins | 3 | 2005 | 116 | 0.300 |
Why?
|
| Trans-Activators | 3 | 2005 | 192 | 0.300 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2021 | 157 | 0.290 |
Why?
|
| Astrocytes | 2 | 2024 | 244 | 0.280 |
Why?
|
| Tumor Burden | 2 | 2020 | 84 | 0.270 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2023 | 57 | 0.270 |
Why?
|
| Female | 18 | 2024 | 24698 | 0.250 |
Why?
|
| Arginine | 3 | 2023 | 75 | 0.250 |
Why?
|
| Isomerism | 4 | 2013 | 64 | 0.240 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2019 | 166 | 0.240 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 561 | 0.240 |
Why?
|
| Sophora | 1 | 2025 | 1 | 0.230 |
Why?
|
| Oxidopamine | 1 | 2025 | 23 | 0.230 |
Why?
|
| Diabetic Nephropathies | 1 | 2025 | 78 | 0.220 |
Why?
|
| Edema | 3 | 2015 | 26 | 0.220 |
Why?
|
| Fasting | 1 | 2024 | 56 | 0.220 |
Why?
|
| Glycolysis | 1 | 2024 | 71 | 0.220 |
Why?
|
| Metformin | 1 | 2025 | 75 | 0.210 |
Why?
|
| Thioredoxin-Disulfide Reductase | 2 | 2015 | 7 | 0.210 |
Why?
|
| Sericins | 1 | 2023 | 1 | 0.200 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2023 | 4 | 0.200 |
Why?
|
| Genes, Reporter | 3 | 2015 | 148 | 0.200 |
Why?
|
| Malondialdehyde | 2 | 2015 | 42 | 0.200 |
Why?
|
| Anniversaries and Special Events | 1 | 2023 | 6 | 0.200 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 259 | 0.190 |
Why?
|
| Fever | 2 | 2015 | 62 | 0.190 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2023 | 54 | 0.190 |
Why?
|
| Adipose Tissue, White | 2 | 2022 | 18 | 0.190 |
Why?
|
| Renin-Angiotensin System | 1 | 2022 | 48 | 0.190 |
Why?
|
| Melatonin | 1 | 2023 | 82 | 0.190 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 158 | 0.190 |
Why?
|
| Isoenzymes | 3 | 2025 | 168 | 0.190 |
Why?
|
| Behavior, Animal | 1 | 2025 | 373 | 0.190 |
Why?
|
| Kidney | 2 | 2023 | 372 | 0.190 |
Why?
|
| Mevalonic Acid | 1 | 2022 | 12 | 0.180 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2015 | 47 | 0.180 |
Why?
|
| Stomach Ulcer | 2 | 2013 | 8 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2023 | 171 | 0.180 |
Why?
|
| Plant Extracts | 1 | 2025 | 302 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 161 | 0.180 |
Why?
|
| Anhydrides | 1 | 2021 | 1 | 0.180 |
Why?
|
| Cell Division | 5 | 2005 | 311 | 0.180 |
Why?
|
| Intestinal Absorption | 1 | 2021 | 22 | 0.170 |
Why?
|
| Hyperuricemia | 1 | 2021 | 14 | 0.170 |
Why?
|
| Uric Acid | 1 | 2021 | 29 | 0.170 |
Why?
|
| Biology | 1 | 2021 | 20 | 0.170 |
Why?
|
| Drug Synergism | 1 | 2022 | 195 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 213 | 0.170 |
Why?
|
| Citric Acid | 1 | 2021 | 15 | 0.170 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 228 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 140 | 0.170 |
Why?
|
| Insulin | 5 | 2021 | 258 | 0.170 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 74 | 0.170 |
Why?
|
| Adiposity | 2 | 2021 | 157 | 0.170 |
Why?
|
| Prediabetic State | 1 | 2022 | 69 | 0.170 |
Why?
|
| Medicine | 1 | 2021 | 37 | 0.170 |
Why?
|
| Animal Experimentation | 1 | 2020 | 3 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 62 | 0.170 |
Why?
|
| Amino Acids | 1 | 2021 | 148 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 316 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2022 | 195 | 0.160 |
Why?
|
| Gold | 1 | 2022 | 156 | 0.160 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2020 | 1 | 0.160 |
Why?
|
| Thiazolidinediones | 1 | 2020 | 49 | 0.160 |
Why?
|
| Mitochondria, Liver | 3 | 2011 | 15 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 384 | 0.160 |
Why?
|
| Agrochemicals | 1 | 2020 | 6 | 0.160 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2020 | 13 | 0.160 |
Why?
|
| Medicago sativa | 1 | 2020 | 9 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2020 | 50 | 0.160 |
Why?
|
| Curcumin | 1 | 2021 | 118 | 0.160 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 40 | 0.160 |
Why?
|
| Pain Threshold | 1 | 2020 | 34 | 0.160 |
Why?
|
| Neurons | 2 | 2024 | 1263 | 0.160 |
Why?
|
| Mice, SCID | 1 | 2020 | 158 | 0.150 |
Why?
|
| Macrophage Activation | 1 | 2020 | 61 | 0.150 |
Why?
|
| Cysteine | 1 | 2020 | 103 | 0.150 |
Why?
|
| Neuralgia | 1 | 2020 | 22 | 0.150 |
Why?
|
| Streptozocin | 4 | 2020 | 26 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2020 | 187 | 0.150 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 263 | 0.150 |
Why?
|
| RNA, Messenger | 5 | 2023 | 1271 | 0.150 |
Why?
|
| Sulfurtransferases | 1 | 2019 | 2 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2021 | 201 | 0.150 |
Why?
|
| Hyperthyroidism | 1 | 2019 | 8 | 0.150 |
Why?
|
| Spinal Cord | 1 | 2020 | 114 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 299 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 196 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 2020 | 307 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2018 | 21 | 0.140 |
Why?
|
| Research Design | 1 | 2020 | 385 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 140 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2018 | 37 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2023 | 460 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 51 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 77 | 0.130 |
Why?
|
| Gene Expression | 2 | 2023 | 701 | 0.130 |
Why?
|
| Microglia | 2 | 2023 | 208 | 0.130 |
Why?
|
| Stereoisomerism | 2 | 2015 | 169 | 0.130 |
Why?
|
| Luciferases | 2 | 2015 | 71 | 0.130 |
Why?
|
| Hippocampus | 1 | 2020 | 594 | 0.130 |
Why?
|
| Mitochondria | 1 | 2020 | 523 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 367 | 0.120 |
Why?
|
| Myocardium | 1 | 2019 | 263 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2018 | 172 | 0.120 |
Why?
|
| Glucose Tolerance Test | 3 | 2022 | 75 | 0.120 |
Why?
|
| Cytokines | 1 | 2020 | 678 | 0.120 |
Why?
|
| Platelet Aggregation | 1 | 2015 | 21 | 0.120 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 36 | 0.120 |
Why?
|
| Sheep | 1 | 2015 | 77 | 0.120 |
Why?
|
| Analgesics | 1 | 2015 | 55 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 77 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 71 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2015 | 260 | 0.110 |
Why?
|
| Models, Molecular | 2 | 2020 | 876 | 0.110 |
Why?
|
| Blood Glucose | 3 | 2022 | 389 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2004 | 508 | 0.110 |
Why?
|
| Time Factors | 2 | 2015 | 1857 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2013 | 5 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2019 | 456 | 0.100 |
Why?
|
| Bone Density | 2 | 2025 | 103 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 518 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2005 | 561 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2005 | 291 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 1001 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2013 | 462 | 0.090 |
Why?
|
| Cyclic GMP | 3 | 2023 | 53 | 0.090 |
Why?
|
| Enzyme Induction | 2 | 2009 | 52 | 0.090 |
Why?
|
| Peptic Ulcer | 1 | 2012 | 15 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 945 | 0.090 |
Why?
|
| Sodium Fluoride | 1 | 2011 | 11 | 0.090 |
Why?
|
| Glucuronosyltransferase | 1 | 2011 | 29 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 99 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 140 | 0.090 |
Why?
|
| Acetylation | 1 | 2011 | 107 | 0.090 |
Why?
|
| Cardiolipins | 1 | 2011 | 12 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2023 | 388 | 0.080 |
Why?
|
| Nitroso Compounds | 1 | 2010 | 12 | 0.080 |
Why?
|
| Phospholipids | 1 | 2011 | 70 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 465 | 0.080 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 42 | 0.080 |
Why?
|
| Stomach | 1 | 2010 | 50 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2011 | 134 | 0.080 |
Why?
|
| Risk Factors | 1 | 2019 | 3994 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 140 | 0.080 |
Why?
|
| Aged | 1 | 2022 | 8214 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2009 | 44 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2010 | 154 | 0.070 |
Why?
|
| RNA Interference | 1 | 2010 | 247 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 592 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 883 | 0.070 |
Why?
|
| Biological Products | 1 | 2009 | 91 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 458 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 704 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2005 | 9 | 0.060 |
Why?
|
| Palmitoylcarnitine | 1 | 2005 | 1 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 35 | 0.060 |
Why?
|
| Lactones | 1 | 2005 | 23 | 0.060 |
Why?
|
| Sulfones | 1 | 2005 | 47 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 148 | 0.050 |
Why?
|
| Genes, APC | 1 | 2004 | 15 | 0.050 |
Why?
|
| Animals, Laboratory | 1 | 2023 | 3 | 0.050 |
Why?
|
| Weight Loss | 1 | 2024 | 137 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2004 | 26 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2024 | 102 | 0.050 |
Why?
|
| Leukemoid Reaction | 1 | 2023 | 1 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2023 | 83 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 1766 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2023 | 32 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2023 | 127 | 0.050 |
Why?
|
| Progesterone | 1 | 2023 | 121 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 224 | 0.050 |
Why?
|
| I-kappa B Kinase | 1 | 2023 | 51 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 2 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2022 | 55 | 0.050 |
Why?
|
| Bone Resorption | 1 | 2021 | 22 | 0.050 |
Why?
|
| Drug Carriers | 1 | 2023 | 174 | 0.040 |
Why?
|
| Iran | 1 | 2022 | 202 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 32 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2023 | 144 | 0.040 |
Why?
|
| DNA Repair | 1 | 2023 | 198 | 0.040 |
Why?
|
| Gastric Juice | 1 | 2021 | 3 | 0.040 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2021 | 3 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2021 | 23 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2023 | 188 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2021 | 33 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2021 | 32 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 143 | 0.040 |
Why?
|
| Arginase | 1 | 2020 | 15 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 277 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 151 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 80 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 104 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2020 | 46 | 0.040 |
Why?
|
| Species Specificity | 1 | 2021 | 286 | 0.040 |
Why?
|
| Naphthyridines | 1 | 2020 | 5 | 0.040 |
Why?
|
| Benzoxazoles | 1 | 2020 | 10 | 0.040 |
Why?
|
| Water | 1 | 2022 | 316 | 0.040 |
Why?
|
| Carbachol | 1 | 2020 | 18 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 181 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 183 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 84 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2023 | 986 | 0.040 |
Why?
|
| Acclimatization | 1 | 2020 | 25 | 0.040 |
Why?
|
| Skin | 1 | 2021 | 187 | 0.040 |
Why?
|
| Homeostasis | 1 | 2021 | 192 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 137 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2020 | 57 | 0.040 |
Why?
|
| Droughts | 1 | 2020 | 30 | 0.040 |
Why?
|
| Urea | 1 | 2020 | 46 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2020 | 100 | 0.040 |
Why?
|
| Isoquinolines | 1 | 2020 | 55 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 695 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2020 | 141 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2019 | 22 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 139 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 172 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2021 | 329 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1180 | 0.030 |
Why?
|
| Binding Sites | 2 | 2012 | 671 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1082 | 0.030 |
Why?
|
| Bystander Effect | 1 | 2015 | 15 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 287 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 666 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 826 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 201 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 712 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 26 | 0.030 |
Why?
|
| Astrocytoma | 1 | 2013 | 17 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 2005 | 155 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 105 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 165 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2013 | 269 | 0.020 |
Why?
|
| Phenylethyl Alcohol | 1 | 2012 | 3 | 0.020 |
Why?
|
| Indomethacin | 1 | 2012 | 25 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 239 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 1621 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2005 | 1869 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 43 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2006 | 56 | 0.020 |
Why?
|
| Pancreas | 1 | 2006 | 45 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 56 | 0.020 |
Why?
|
| Cricetinae | 1 | 2006 | 241 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 98 | 0.010 |
Why?
|
| Carcinogens | 1 | 2006 | 126 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 13872 | 0.010 |
Why?
|
| Catalysis | 1 | 2005 | 187 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 294 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 200 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2004 | 75 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2004 | 25 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 2003 | 17 | 0.010 |
Why?
|
| Colon | 1 | 2004 | 120 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 983 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 92 | 0.010 |
Why?
|
| Cadherins | 1 | 2003 | 102 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 134 | 0.010 |
Why?
|
| Proteins | 1 | 2005 | 382 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 575 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 532 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 429 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 383 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 665 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 934 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 278 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2004 | 434 | 0.010 |
Why?
|